Published in Cancer Med on April 21, 2013
Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis. PLoS One (2015) 0.87
Triage of high-risk human papillomavirus-positive women by methylated POU4F3. Clin Epigenetics (2015) 0.82
Anal Cancer Screening in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2016) 0.78
Systematic Comparison of Different Meta-analyses, Systematic Reviews and HTA Reports on Cervical Cancer Screening based on Cytology or HPV Test. Geburtshilfe Frauenheilkd (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA (2002) 15.59
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
HPV screening for cervical cancer in rural India. N Engl J Med (2009) 14.13
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med (2007) 9.53
Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med (1999) 9.40
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol (2003) 7.54
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol (2010) 7.29
Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol (2006) 6.60
Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med (2007) 5.57
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol (2011) 3.66
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med (2002) 3.61
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol (2011) 3.58
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.40
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst (2004) 3.20
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine (2006) 3.15
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst (2003) 3.08
Regression of low-grade squamous intra-epithelial lesions in young women. Lancet (2004) 2.98
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol (2007) 2.97
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol (2007) 2.91
Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol (2003) 2.71
HPV testing in primary screening of older women. Br J Cancer (1999) 2.44
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer (2007) 2.39
2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol (2003) 2.25
Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev (2008) 2.20
The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res (2006) 2.08
Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol (2008) 1.85
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst (2003) 1.84
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol (2006) 1.77
A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. Am J Clin Pathol (2005) 1.73
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol (2005) 1.70
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol (2007) 1.66
Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer (2011) 1.57
Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol (2010) 1.56
Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet (2001) 1.56
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer (2012) 1.53
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer (2011) 1.34
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev (2003) 1.29
Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study. Int J Cancer (2008) 1.27
Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther (2010) 1.27
Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol (2006) 1.24
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer (2008) 1.13
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening. Br J Cancer (2005) 1.12
Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol (2009) 1.12
Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J Clin Virol (2002) 1.09
Detection of HPV DNA in cervical specimens collected in cytologic solution by ligation-dependent PCR. Acta Cytol (2003) 1.09
Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears. J Med Virol (2010) 1.07
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J Clin Microbiol (2003) 1.05
Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. J Clin Microbiol (2011) 1.02
Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol (2007) 1.02
Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol (2000) 1.01
Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol (2009) 1.00
Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn Mol Pathol (1999) 0.99
Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results. J Clin Virol (2007) 0.93
Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol (2005) 0.90
Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women. Gynecol Oncol (2011) 0.84
Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease. J Clin Microbiol (2006) 0.83
Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device. Acta Obstet Gynecol Scand (2007) 0.83
Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance. J Clin Microbiol (2006) 0.81
Efficacy of Abbott RealTime High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population. J Clin Virol (2011) 0.80
Gynecological cancer: More evidence supporting human papillomavirus testing. Nat Rev Clin Oncol (2012) 0.78
Molecular strategies for identifying human papillomavirus infection in routinely processed samples: focus on paraffin sections. J Low Genit Tract Dis (2005) 0.78
Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear. J Virol Methods (2007) 0.77
Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison. Acta Cytol (2004) 0.76
Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay. Clin Microbiol Infect (2009) 0.76
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
Five roles for using theory and evidence in the design and testing of behavior change interventions. J Public Health Dent (2011) 3.90
Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 3.05
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr (2002) 2.16
Contraception or abortion? Inaccurate descriptions of emergency contraception in newspaper articles, 1992-2002. Contraception (2005) 2.15
Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med (2007) 2.06
Measuring the prevalence of overweight in Texas schoolchildren. Am J Public Health (2004) 1.97
Cancer control planners' perceptions and use of evidence-based programs. J Public Health Manag Pract (2010) 1.75
Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg (2008) 1.69
A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer (2011) 1.68
A systematic development process for patient decision aids. BMC Med Inform Decis Mak (2013) 1.62
Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 1.51
An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer (2012) 1.49
Association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomarkers Prev (2009) 1.41
A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine (2010) 1.41
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Clin Cancer Res (2010) 1.28
Preventing postpartum smoking relapse among diverse low-income women: a randomized clinical trial. Nicotine Tob Res (2010) 1.27
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol (2015) 1.27
A history of patient education by health professionals in Europe and North America: from authority to shared decision making education. Patient Educ Couns (2010) 1.17
Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol (2010) 1.15
DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (2002) 1.12
The Childhood Leukemia International Consortium. Cancer Epidemiol (2013) 1.09
Primary care physicians' use of an informed decision-making process for prostate cancer screening. Ann Fam Med (2013) 1.08
Baby BEEP: A randomized controlled trial of nurses' individualized social support for poor rural pregnant smokers. Matern Child Health J (2008) 1.07
Continuing medical education: what delivery format do physicians prefer? J Contin Educ Health Prof (2003) 1.06
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother (2012) 1.04
The effects of smoking cessation counseling by midwives on Dutch pregnant women and their partners. Patient Educ Couns (2006) 1.03
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer (2010) 1.00
A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT. Patient Educ Couns (2011) 1.00
Examining the association between oral health and oral HPV infection. Cancer Prev Res (Phila) (2013) 1.00
Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res (2010) 0.99
Correlates of mammography screening among Hispanic women living in lower Rio Grande Valley farmworker communities. Health Educ Behav (2005) 0.98
Beyond reading level: a systematic review of the suitability of cancer education print and Web-based materials. J Cancer Educ (2010) 0.97
Research results: preserving newborn blood samples. Sci Transl Med (2012) 0.97
Translating cancer prevention and control research into the community setting: workforce implications. J Cancer Educ (2012) 0.95
A protocol for the analytical aspects of a systematic review of HIV prevention research. J Acquir Immune Defic Syndr (2002) 0.94
Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer (2013) 0.94
Computer-based decision support for pediatric asthma management: description and feasibility of the Stop Asthma Clinical System. Health Informatics J (2006) 0.94
Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol (2009) 0.94
p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis (2008) 0.94
What is the evidence for pharmaceutical patient assistance programs? A systematic review. J Health Care Poor Underserved (2011) 0.93
Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data. Cancer Causes Control (2013) 0.93
Breast feeding is associated with postpartum smoking abstinence among women who quit smoking due to pregnancy. Nicotine Tob Res (2010) 0.91
A minimal intervention to promote smoke-free homes among 2-1-1 callers: a randomized controlled trial. Am J Public Health (2015) 0.91
Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma. Pediatr Blood Cancer (2012) 0.90
Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia. Gynecol Oncol (2007) 0.89
A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck (2005) 0.89
Mediators of the association of major depressive syndrome and anxiety syndrome with postpartum smoking relapse. J Consult Clin Psychol (2012) 0.89
The meaning of health for women with physical disabilities: a qualitative analysis. Fam Community Health (2004) 0.89
Pathways linking socioeconomic status and postpartum smoking relapse. Ann Behav Med (2013) 0.89
Parent-based adolescent sexual health interventions and effect on communication outcomes: a systematic review and meta-analyses. Perspect Sex Reprod Health (2015) 0.87
Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. Cancer Epidemiol (2013) 0.87
Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck (2012) 0.87
Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Prostate (2011) 0.86
Predictors of survival among older adults with ependymoma. J Neurooncol (2011) 0.86
A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer (2002) 0.86
Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys (2005) 0.86
Anal cancer incidence and survival: comparing the greater San-Francisco bay area to other SEER cancer registries. PLoS One (2013) 0.85
Risk factors for oligodendroglial tumors: a pooled international study. Neuro Oncol (2010) 0.85
Optical technologies and molecular imaging for cervical neoplasia: a program project update. Gend Med (2011) 0.85
Pilot study to develop a rapid assessment of tuberculosis care-seeking and adherence practices in rural Limpopo Province, South Africa. Int Q Community Health Educ (2011) 0.84
Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007. Neuroepidemiology (2012) 0.84
Chromosomally-integrated human herpesvirus 6 in familial glioma etiology. Med Hypotheses (2012) 0.84
The association between birth order, sibship size and glioma development in adulthood. Int J Cancer (2010) 0.84
Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. Am J Prev Med (2008) 0.84
Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Int J Cancer (2013) 0.84
Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res (2013) 0.83
The future workforce in cancer prevention: advancing discovery, research, and technology. J Cancer Educ (2012) 0.83
Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program. J Neurooncol (2014) 0.82
Nativity differences in behaviors associated with high-risk HPV infection among Hispanic women in Houston, Texas, USA. J Immigr Minor Health (2013) 0.82
Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res (2013) 0.82
Integration of epidemiology, immunobiology, and translational research for brain tumors. Ann N Y Acad Sci (2013) 0.82
Condom use among sterilized and nonsterilized women in county jail and residential treatment centers. Womens Health Issues (2010) 0.82
Physician behaviors to promote informed decisions for prostate cancer screening: a National Research Network study. J Cancer Educ (2014) 0.81
Race/ethnicity moderates the effect of prepartum menthol cigarette use on postpartum smoking abstinence. Nicotine Tob Res (2011) 0.81
'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer. Psychooncology (2013) 0.81
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet (2012) 0.81
Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. Gend Med (2012) 0.81
Associations between vaccination and childhood cancers in Texas regions. J Pediatr (2011) 0.81
Reporting guidelines: optimal use in preventive medicine and public health. Am J Prev Med (2012) 0.81
The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiol Biomarkers Prev (2008) 0.81
HPV vaccination. Inaccurate assumptions about oropharyngeal cancer. BMJ (2009) 0.81
Feasibility of implementation of a Dutch smoking cessation and relapse prevention protocol for pregnant women. Patient Educ Couns (2003) 0.81
Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol (2013) 0.81
Genetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma (2014) 0.81
Children's skin cancer prevention: a systematic review of parents' psychosocial measures. Am J Prev Med (2013) 0.80
A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control (2012) 0.80
Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings. Clin Med Insights Oncol (2013) 0.80
Evolving evidence on tumor and germline genetic classification of gliomas: implications for etiology and survival studies. Clin Neuropathol (2015) 0.79
Clinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors? Future Oncol (2013) 0.79
Psychiatric distress in incarcerated women with recent cocaine and alcohol abuse. Womens Health Issues (2007) 0.78
RE: "Lack of association of herpesviruses with brain tumors". J Neurovirol (2007) 0.78
CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women. J Infect Dis (2012) 0.78
Gamma radiation-induced apoptosis, G2 delay, and the risk of salivary and thyroid carcinomas--a preliminary report. Head Neck (2004) 0.78
Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis. Cancer Med (2013) 0.78
Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro Oncol (2012) 0.77
Introducing the community guide's reviews of evidence on interventions to increase screening for breast, cervical, and colorectal cancers. Am J Prev Med (2008) 0.77
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas. J Virol (2014) 0.77